Should Shares CRISPR Therapeutics Be a February Pick?
Biotech investors chase game-changing tech, but CRISPR Therapeutics carries real regulatory milestones and execution ...
Learn various ways to cut costs on a limited budget. Make smarter financial choices and save effectively.
21,848 articlesBiotech investors chase game-changing tech, but CRISPR Therapeutics carries real regulatory milestones and execution ...
DES delivers monthly payouts tied to a cash-dividend weighted small-cap index. The income looks reliable, but a conce...
Dragonfly Capital closes a $650 million fund to back early-stage crypto ventures as liquidity tightens and token pric...
SpaceX is shaping up to launch its IPO, and the idea of could buying spacex stock sounds thrilling. This guide breaks...
FMC stock has seen a sharp drop, prompting questions about value and timing. This guide breaks down how to tell if th...
Iovance Biotherapeutics has shown dramatic swings, with recent gains masking a long history of volatility. This piece...
A large holder trimmed a substantial stake in a biotech name while the stock advanced. This piece explains what inves...
Income-focused investors are turning to a small group of high-yield energy names that offer cash-flow visibility and ...
As markets wobble in early 2026, a handful of Dow Jones dividend stocks offer reliable income for retirees. This repo...
AI is accelerating frontline work even as executive teams struggle to adapt. Leaders must redesign decision-making to...
U.S. labor data at month-end point to a cooling but stable job market, with initial claims around the low 200,000s an...
Premu launches a new feature that lets anyone create World Cup markets with up to 2.5x leverage and collect trading f...